2022-05-23| COVID-19Special

Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel

by Reed Slater
Share To

Over two years into the COVID-19 pandemic, the world has experienced and learned so much about viruses, epidemic response, vaccine technology, and everything else that comes along with living through a global epidemic. At the Future of Everything Festival, Moderna CEO Stéphane Bancel sits down and recounts some valuable lessons the pharmaceutical giant has learned over this time and highlights some hopeful prospects for the future after the pandemic. 


Where COVID May Be Heading


Over 6 million people worldwide have died due to COVID-19 since it began in late 2019. However, the dominant variant, Omicron, is less dangerous than its predecessors. Though much more virulent, Omicron shows milder symptoms across the board and, compared to Alpha and Delta, is showing signs it may be the light at the end of the tunnel. 

It's free! Log in now to read

Kite’s Yescarta Yields a Success in a Phase 3 Trial for Treating Large B-Cell Lymphoma
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
Comparing ESG Regulations in the U.S., the U.K., and the EU
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
Scroll to Top